Table 3, Summary of included studies for Comparison 2: Collaborative care versus standard care for relapse prevention - Service delivery Models and settings for delivery of services

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Service delivery Models and settings for delivery of services: Depression in adults: Evidence review A. London: National Institute for Health and Care Excellence (NICE); 2022 Jun. (NICE Guideline, No. 222.)

Cover of Service delivery Models and settings for delivery of services

Service delivery Models and settings for delivery of services: Depression in adults: Evidence review A.

Show details

Table 3Summary of included studies for Comparison 2: Collaborative care versus standard care for relapse prevention

Study	Population	Intervention	Comparison	Comments
Katon 2001 RCT US	N=386 Baseline severity: Recovered but at high risk of relapse (<4 DSM-IV MDD symptoms and a history of ≥3 episodes of MDD or dysthymia or 4 residual depressive symptoms but mean SCL-20 depression score < 1.0 and a history of MDD/dysthymia) Mean age (years): 46 Sex (% female): 74 Ethnicity (% BME): 10	Simple collaborative care Collaborative care component score: 9	Standard care	Duration of programme contact (in months): 12 Outcomes: Relapse at 12 months Antidepressant use at 6 months Antidepressant use at 12 months Discontinuation at 12 months

Study

Population

Intervention

Comparison

Comments

Katon 2001

RCT

N=386

Baseline severity: Recovered but at high risk of relapse (<4 DSM-IV MDD symptoms and a history of ≥3 episodes of MDD or dysthymia or 4 residual depressive symptoms but mean SCL-20 depression score < 1.0 and a history of MDD/dysthymia)

Mean age (years): 46

Sex (% female): 74

Ethnicity (% BME): 10

Simple collaborative care

Collaborative care component score: 9

Standard care

Duration of programme contact (in months): 12

Outcomes:

Relapse at 12 months
Antidepressant use at 6 months
Antidepressant use at 12 months
Discontinuation at 12 months

: BME: black minority ethnic; DSM: diagnostic statistical manual; MDD: major depressive disorder; N: number; NR: not reported; RCT: randomised controlled trial; SCL-20: symptom checklist

From: Service delivery Models and settings for delivery of services

Views

Cite this Page
Service delivery Models and settings for delivery of services: Depression in adults: Evidence review A. London: National Institute for Health and Care Excellence (NICE); 2022 Jun. (NICE Guideline, No. 222.) Table 3, Summary of included studies for Comparison 2: Collaborative care versus standard care for relapse prevention.
PDF version of this title (5.2M)

Other titles in this collection

NICE Evidence Reviews Collection

Related NICE guidance and evidence

NICE Guideline 222: Depression in adults: treatment and management

Related information

PubMed
Links to PubMed

Recent Activity

Clear Turn Off Turn On

Table 3, Summary of included studies for Comparison 2: Collaborative care versus...
Table 3, Summary of included studies for Comparison 2: Collaborative care versus standard care for relapse prevention - Service delivery Models and settings for delivery of services
PREDICTED: Homo sapiens FA complementation group L (FANCL), transcript variant X...
PREDICTED: Homo sapiens FA complementation group L (FANCL), transcript variant X7, mRNA
gi|2462574653|ref|XM_054342721.1|
Nucleotide
Chrozophora sabulosa voucher TW-0270 maturase K (matK) gene, partial cds; chloro...
Chrozophora sabulosa voucher TW-0270 maturase K (matK) gene, partial cds; chloroplast
gi|2274954928|gb|MT929923.1|
Nucleotide
SW620_mRNA_gDNA-seq_Rep2
SW620_mRNA_gDNA-seq_Rep2
biosample
Chrozophora sabulosa voucher Q-177 maturase K (matK) gene, partial cds; chloropl...
Chrozophora sabulosa voucher Q-177 maturase K (matK) gene, partial cds; chloroplast
gi|2274954940|gb|MT929929.1|
Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on